Sign in
Taking people in United StatesNo phase

Testing earlier screening for gestational diabetes in early pregnancy

Tests whether screening for gestational diabetes in the first trimester is workable and acceptable.

Key facts

Who runs it
University of Massachusetts, Worcester
Where
Worcester, United StatesSee the site
Trial code
Registry title
Early Detection of Gestational Diabetes Mellitus in Pregnancy
Status
Recruiting
People taking part
80 people, planned
Started
1 Jul 2025
Expected to end
1 Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Enhanced First Trimester GDM Screening
  • Routine Gestational Diabetes Screening
Record updated
6 April 2026

Who can take part

The trial is looking for pregnant women early in pregnancy who are at high risk of diabetes during pregnancy (gestational diabetes). It tests early blood sugar screening in the first trimester.

Age
18 years or older.
Sex
Women only.
Disease stage
Pregnant with one baby, 12 weeks or less at the first pregnancy visit. High risk of gestational diabetes by ACOG clinical risk factor guidelines. Must get pregnancy care and plan to give birth at UMMHC. Must speak English or Spanish.
Main reasons for not taking part
  • Diabetes known from before the pregnancy
  • Plans to get pregnancy care or give birth outside UMMHC
  • Unable to complete an oral glucose tolerance test, for example after gastric bypass surgery, dumping syndrome or vomiting the test drink
  • Use of steroid medicines that act on the whole body

This trial only enrols pregnant participants. The registry sentence this rests on: * 2) singleton gestation less than or equal to 12 weeks at initial obstetric visit,

Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • 1) age greater than or equal to 18 years old,
  • 2) singleton gestation less than or equal to 12 weeks at initial obstetric visit,
  • 3) receiving prenatal care at UMMHC and plans to deliver at UMMHC,
  • 4) able and willing to provide informed consent,
  • 5) English or Spanish speaking, and
  • 6) are at high risk for developing GDM by ACOG clinical risk factor guidelines

Who cannot take part

  • 4) systemic steroid use
  • 1) known diagnosis of pre-existing pregestational diabetes,
  • 3) inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test), or
  • 2) plan to receive prenatal care or deliver outside of UMMHC,

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Sex
  • Gestational diabetes mellitus in pregnancy

This trial is currently available in United States.

  • University of Massachusetts Memorial Medical CenterWorcester, United StatesContact: Gianna L Wilkie, MDTaking people

About the trial

What the trial wants to find out

The purpose of this study is to develop an implementation protocol and test the feasibility and acceptability of a first trimester screening protocol for the early detection of gestational diabetes mellitus (GDM).

The 2 groups in the trial

  • Enhanced First Trimester GDM ScreeningTreatment being tested

    Women who are randomly assigned to this condition will be required to have early glucose screening with a prediction model composed of additional clinical risk factors and serum biomarkers (triglycerides, PAPP-A, and lipocalin-2) with their initial prenatal laboratory assessment.

  • Standard of Care GDM ScreeningExisting treatment, for comparison

    Women who will be randomized to the comparison condition of usual standard of care will undergo routine standard of care. The standard of care will consist of routine screening for diabetes in pregnancy between 24 to 28 weeks of gestation via the two-step screening method with possible early screening with either plasma fasting glucose, oral glucose tolerance test, or hemoglobin A1c at the providers discretion to represent true clinical practice.

    Treatment: Routine Gestational Diabetes Screening

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early Detection of Gestational Diabetes Mellitus in Pregnancy: A Randomized Trial
Plain-language title
Testing earlier screening for gestational diabetes in early pregnancyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT05388643, who can take part
Record updated
6 April 2026